Corrigendum: Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis

In the original article, there was a mistake in Figure 2 as published. The Figure 1 was accidentally duplicated in the proof stage. The correct Figure 2 appears below.

FIGURE 2.

Effects of TDC on noninvasive blood pressure in SHR (A–C) Representative data plots of SBP, DBP, and MBP measurements, respectively, over 4 weeks using the noninvasive tail-cuff method in conscious rats (D) Bar graph comparison of the MBP in the four rat groups at day 28. Data are expressed as mean ± SD, n = 5–6. ****p < 0.0001 vs. WKY rats; ##p < 0.01, ###p < 0.001 vs. SHR.>

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.